Sabra Health Care REIT, Inc.

Equities

SBRA

US78573L1061

Specialized REITs

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
13.77 USD +0.81% Intraday chart for Sabra Health Care REIT, Inc. +1.25% -3.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance MT
Earnings Flash (SBRA) SABRA HEALTH CARE REIT Posts Q4 Revenue $163.4M MT
Sabra Health Care REIT, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on February 29, 2024 CI
Sabra Health Care REIT, Inc. Provides Earnings Guidance for the Year 2024 CI
Sabra Health Care REIT, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Deutsche Bank Initiates Coverage on Sabra Health Care REIT With Buy Rating, $21 Price Target MT
Sabra Health Care Names Jessica Flores as Chief Accounting Officer MT
Sabra Health Care REIT, Inc. Announces Executive Changes CI
Mizuho Adjusts Sabra Health Care REIT's Price Target to $17 From $15, Maintains Buy Rating MT
Transcript : Sabra Health Care REIT, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Stifel Increases Price Target on Sabra Health Care REIT to $16 From $14, Maintains Buy Rating MT
Sabra Health Care Posts Lower Q3 FFO, Higher Revenue MT
Earnings Flash (SBRA) SABRA HEALTH CARE REIT Posts Q3 Revenue $161.6M MT
Sabra Health Care REIT, Inc. Declares a Quarterly Cash Dividend, Payable on November 30, 2023 CI
Sabra Health Care REIT, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BMO Capital Downgrades Sabra Health Care REIT to Market Perform From Outperform, $16 Price Target MT
Wells Fargo Upgrades Sabra Health Care REIT to Equalweight From Underweight, Raises Price Target to $15 From $11 MT
BofA Securities Upgrades Sabra Health Care REIT to Buy From Neutral MT
Wedbush Starts Sabra Health Care REIT at Outperform With $16 Price Target MT
Jefferies Upgrades Sabra Health Care REIT to Buy From Hold, Adjusts Price Target to $15 From $11 MT
US Nursing Homes Will Have to Maintain Minimum Staffing Levels Under Biden Administration Proposal MT
Medical Properties Trust Faces Tenant Credit Risk While Sabra Health Care May Benefit From Senior Housing Recovery, BofA Securities Says MT
BofA Securities Upgrades Sabra Health Care REIT to Neutral From Underperform, Adjusts Price Target to $14 From $11 MT
Chart Sabra Health Care REIT, Inc.
More charts
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust (REIT) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment include approximately 37,834 beds/units, spread across the United States and Canada.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
13.78 USD
Average target price
15.91 USD
Spread / Average Target
+15.45%
Consensus
  1. Stock Market
  2. Equities
  3. SBRA Stock
  4. News Sabra Health Care REIT, Inc.
  5. Sabra Health Care REIT : Earnings Flash (SBRA) SABRA HEALTH CARE REIT Posts Q2 Revenue $152.9M